Paris, France - The 12th edition of the New Horizons Scientific Conference organized by MicroPort® CRM, which is a subsidiary of MicroPort® Scientific Corporation (“MicroPort®”), was recently held in Paris. Angelo Auricchio, David Hayes, Francisco Leyva and Philippe Mabo, who are experts from Switzerland, the US, Britain and France respectively, were the joint chairpersons. Nearly 30 pacemaker electrophysiology and heart failure experts from over ten countries gave lectures. The conference attracted more than 250 cardiologists from nearly 20 countries to take part in exchanges, with the presence of Chinese physicians for the first time.
MicroPort® CRM President Benoit Clinchamps said in the opening remark that MicroPort® CRM has been engaged in the pacing sector for over four decades with a total of 1,100 patents or patent applications and over 1,000 employees globally. As a new subsidiary under MicroPort®, MicroPort® CRM will continue to be committed to innovation and R&D of more high-quality rhythm management products, and to commercialize high cost-performance-ratio medical solutions that can save and reshape patients’ lives or improve their quality of life.
The conference covered the topics of heart failure CRT's pre-surgery patient choice, implantation technologies and after-surgery patient management in the forms of lectures, face-to-face discussions with the experts and debates. The conference provided a deeper knowledge of MicroPort® and MicroPort® CRM for the over 250 experts present from around the world. It also deepened their willingness for close cooperation with the corporations in the future.
MicroPort® Chairman and Chief Executive Officer Dr. Chang Zhaohua said, "MicroPort® will continue to sponsor New Horizons Scientific Conference, enhance communication with experts and physicians in the sector, and provide a bigger exchange platform for the R&D and business of cardiac rhythm management."
MicroPort® CRM develops, manufactures and markets products including defibrillators, cardiac resynchronization therapy devices and pacemakers for the diagnosis, treatment and management of heart rhythm disorders and heart failures, based on its legacy of more than one million patients implanted globally over nearly four decades. Among the products, Kora™ series are the world's smallest full-body MRI conditional pacemakers, which make MRI scans no longer off-limits for pacemaker patients with the world’s first pacemaker technology capable of detecting an MRI field and automatically switching to asynchronous mode. Platinium Implantable Cardioverter Defibrillator (ICD) has the world's longest projected longevity of 14.3 years, giving the patients more durable and reliable safeguard. Platinium Cardiac Resynchronization Therapy Defibrillator (CRT-D) features the world's only SonR™contractility sensor for automatic CRT optimization, improving heart failure symptoms.
The New Horizons Scientific Conference is held by MicroPort® CRM with 12 editions so far. The conference builds a high-end platform for academic exchanges among global CRM and heart failure experts. It aims to make cardiac resynchronization therapy more popular, laying the solid groundwork for the promotion of new concepts and the application of new technologies.